Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541301
PUBLISHER: IMARC | PRODUCT CODE: 1541301
Gastrointestinal Therapeutics Market Report by Type, Route of Administration, Application, Distribution Channel, and Region 2024-2032
PUBLISHED:
PAGES: 144 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global gastrointestinal therapeutics market size reached US$ 46.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.
Gastrointestinal (GI) syndrome refers to a medical ailment that affects the functioning of organs in the digestive tract. It impacts the stomach, pancreas, small and large intestines, gall bladder and liver and is usually characterized by indigestion, heartburn, constipation and bloating. Some of the commonly used GI therapeutics include prescription and over-the-counter (OTC) drugs, such as antacids, laxatives, antidiarrheal agents, antiemetics, antiulcer agents, and endoscopic and radiological procedures and hematological tests. These therapeutics assist in the detection of the disorder and absorbing nutrients from the food to improve digestion, regulate water flow in the GI system and minimize gastric acidity.
The increasing prevalence of GI diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, is one of the key factors driving the growth of the market. Due to changing lifestyle patterns and unhealthy dietary habits, there is an increased probability of disease recurrence among patients across the globe. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Various technological advancements, such as the development of innovative biosimilars and cellular therapies for the treatment of the disorder, are acting as other growth-inducing factors. These biologics are administered through intravenous and subcutaneous injections and are personalized for targeted treatments. Other factors, including rising health consciousness among the masses, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, especially in developing economies, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gastrointestinal therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, route of administration, application and distribution channel.
Breakup by Type:
Branded
Generic
Breakup by Route of Administration:
Oral
Intravenous
Others
Breakup by Application:
Ulcerative Colitis
Crohn's Disease
GERD
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, GlaxoSmithKline Plc, Janssen Biotech Inc. (Johnson & Johnson), Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceuticals.
Key Questions Answered in This Report:
- How has the global gastrointestinal therapeutics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global gastrointestinal therapeutics market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the route of administration?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global gastrointestinal therapeutics market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112024A3069
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Gastrointestinal Therapeutics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Branded
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Generic
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Route of Administration
- 7.1 Oral
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Intravenous
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Application
- 8.1 Ulcerative Colitis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Crohn's Disease
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 GERD
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
- 9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Online Pharmacies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 AbbVie Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 AstraZeneca Plc
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Bausch Health Companies Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Bayer Aktiengesellschaft
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 GlaxoSmithKline Plc
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Janssen Biotech Inc. (Johnson & Johnson)
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Novo Nordisk A/S
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Pfizer Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Sanofi S.A.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Takeda Pharmaceuticals
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.1 Abbott Laboratories
Product Code: SR112024A3069
List of Figures
- Figure 1: Global: Gastrointestinal Therapeutics Market: Major Drivers and Challenges
- Figure 2: Global: Gastrointestinal Therapeutics Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Gastrointestinal Therapeutics Market: Breakup by Type (in %), 2023
- Figure 5: Global: Gastrointestinal Therapeutics Market: Breakup by Route of Administration (in %), 2023
- Figure 6: Global: Gastrointestinal Therapeutics Market: Breakup by Application (in %), 2023
- Figure 7: Global: Gastrointestinal Therapeutics Market: Breakup by Distribution Channel (in %), 2023
- Figure 8: Global: Gastrointestinal Therapeutics Market: Breakup by Region (in %), 2023
- Figure 9: Global: Gastrointestinal Therapeutics (Branded) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Gastrointestinal Therapeutics (Branded) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Gastrointestinal Therapeutics (Generic) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Gastrointestinal Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Gastrointestinal Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Gastrointestinal Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Gastrointestinal Therapeutics (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Gastrointestinal Therapeutics (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Gastrointestinal Therapeutics (GERD) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Gastrointestinal Therapeutics (GERD) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: North America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: United States: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: United States: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Canada: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Canada: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: North America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Asia-Pacific: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: China: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: China: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Japan: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Japan: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: India: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: India: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: South Korea: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: South Korea: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Australia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Australia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Indonesia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Indonesia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Asia-Pacific: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Europe: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Germany: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Germany: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: France: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: France: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: United Kingdom: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: United Kingdom: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Italy: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Italy: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Spain: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Spain: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Russia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Russia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Europe: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Latin America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Brazil: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Brazil: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Mexico: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Mexico: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Latin America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Middle East and Africa: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Middle East and Africa: Gastrointestinal Therapeutics Market: Breakup by Country (in %), 2023
- Figure 81: Middle East and Africa: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 82: Global: Gastrointestinal Therapeutics Industry: SWOT Analysis
- Figure 83: Global: Gastrointestinal Therapeutics Industry: Value Chain Analysis
- Figure 84: Global: Gastrointestinal Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Gastrointestinal Therapeutics Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
- Table 4: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 5: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
- Table 6: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Gastrointestinal Therapeutics Market: Competitive Structure
- Table 8: Global: Gastrointestinal Therapeutics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.